Taiyen Biotech Co., Ltd. (1737.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.24B |
| Enterprise Value | 5.11B |
| P/E Ratio | 15.69 |
| PEG Ratio | 1.45 |
| Price/Sales Ratio | 1.92 |
| Price/Book Ratio | 0.91 |
| Enterprise/Revenue | 1.5 |
| Enterprise/EBITDA | 7.1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 3.31B |
| Revenue/Share | 15.93 |
| Gross Profit | 1.34B |
| EBITDA | 710.17M |
| Net Income | 399.87M |
| Diluted EPS | 2 |
Balance Sheet
| Total Cash | 1.97B |
| Total Cash/Share | 9.82 |
| Total Debt | 228.22M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 2.48 |
| Book Value Per Share | 33.51 |
Price History
| 52-Week Change | -5.12 |
| 52-Week High | 33 |
| 52-Week Low | 30.45 |
| Moving Average 50 Days | 31.67 |
| Moving Average 200 Days | 31.66 |
Statistics
| Average Volume | 170,846 |
| Shares Outstanding | 200M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.4 |
| Trailing Annual Dividend Yield | 4.58 |
| Payout Ratio | 0.64 |
| Last Split Factor | 719:1000 |
| Last Split Date | December 16, 2013 |
AD
